##  [OMB157](/node/666266 "OMB157") 

  



Kesimpta®

[Neuroscience](/taxonomy/term/2906)

[Phase 3](/taxonomy/term/2776)

[2027](/taxonomy/term/2806)

[CD20 antagonist](/taxonomy/term/4261)

 

Multiple sclerosis, new dosing regimen

[Supplementary Indication](/taxonomy/term/2791)



- [Print](/node/666266/printable/print)
- [PDF](/node/666266/printable/pdf)